These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 29769256)

  • 1. Early use of Antibiotics for at Risk CHildren with InfluEnza (ARCHIE): protocol for a double-blind, randomised, placebo-controlled trial.
    Wang K; Carver T; Tonner S; Semple MG; Hay AD; Moore M; Little P; Butler C; Farmer A; Perera R; Yu LM; Mallett S; Wolstenholme J; Harnden A
    BMJ Open; 2018 May; 8(5):e021144. PubMed ID: 29769256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The early use of Antibiotics for at Risk CHildren with InfluEnza-like illness (ARCHIE): a double-blind randomised placebo-controlled trial.
    Wang K; Semple MG; Moore M; Hay AD; Tonner S; Galal U; Grabey J; Carver T; Perera R; Yu LM; Mollison J; Little P; Farmer A; Butler CC; Harnden A
    Eur Respir J; 2021 Oct; 58(4):. PubMed ID: 33737410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life, healthcare use and costs in 'at-risk' children after early antibiotic treatment versus placebo for influenza-like illness: within-trial descriptive economic analyses of the ARCHIE randomised controlled trial.
    Rombach I; Wang K; Tonner S; Grabey J; Harnden A; Wolstenholme J; ;
    BMJ Open; 2022 Apr; 12(4):e049373. PubMed ID: 35428613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotics for bronchiectasis exacerbations in children: rationale and study protocol for a randomised placebo-controlled trial.
    Chang AB; Grimwood K; Robertson CF; Wilson AC; van Asperen PP; O'Grady KA; Sloots TP; Torzillo PJ; Bailey EJ; McCallum GB; Masters IB; Byrnes CA; Chatfield MD; Buntain HM; Mackay IM; Morris PS
    Trials; 2012 Aug; 13():156. PubMed ID: 22937736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amoxicillin-clavulanate versus azithromycin for respiratory exacerbations in children with bronchiectasis (BEST-2): a multicentre, double-blind, non-inferiority, randomised controlled trial.
    Goyal V; Grimwood K; Byrnes CA; Morris PS; Masters IB; Ware RS; McCallum GB; Binks MJ; Marchant JM; van Asperen P; O'Grady KF; Champion A; Buntain HM; Petsky H; Torzillo PJ; Chang AB
    Lancet; 2018 Oct; 392(10154):1197-1206. PubMed ID: 30241722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of oral amoxicillin-clavulanate or azithromycin for non-severe respiratory exacerbations in children with bronchiectasis (BEST-1): a multicentre, three-arm, double-blind, randomised placebo-controlled trial.
    Goyal V; Grimwood K; Ware RS; Byrnes CA; Morris PS; Masters IB; McCallum GB; Binks MJ; Smith-Vaughan H; O'Grady KF; Champion A; Buntain HM; Schultz A; Chatfield M; Torzillo PJ; Chang AB
    Lancet Respir Med; 2019 Sep; 7(9):791-801. PubMed ID: 31427252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duration of amoxicillin-clavulanate for protracted bacterial bronchitis in children (DACS): a multi-centre, double blind, randomised controlled trial.
    Ruffles TJC; Goyal V; Marchant JM; Masters IB; Yerkovich S; Buntain H; Cook A; Schultz A; Upham JW; Champion A; Versteegh L; Chang AB
    Lancet Respir Med; 2021 Oct; 9(10):1121-1129. PubMed ID: 34048716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous co-amoxiclav to prevent infection after operative vaginal delivery: the ANODE RCT.
    Knight M; Chiocchia V; Partlett C; Rivero-Arias O; Hua X; Bowler U; Gray J; Gray S; Hinshaw K; Khunda A; Moore P; Mottram L; Owino N; Pasupathy D; Sanders J; Sultan AH; Thakar R; Tuffnell D; Linsell L; Juszczak E
    Health Technol Assess; 2019 Oct; 23(54):1-54. PubMed ID: 31590702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antivirals for influenza-Like Illness? A randomised Controlled trial of Clinical and Cost effectiveness in primary CarE (ALIC
    Bongard E; van der Velden AW; Cook J; Saville B; Beutels P; Munck Aabenhus R; Brugman C; Chlabicz S; Coenen S; Colliers A; Davies M; De Paor M; De Sutter A; Francis NA; Glinz D; Godycki-Ćwirko M; Goossens H; Holmes J; Ieven M; de Jong M; Lindbaek M; Little P; Martinón-Torres F; Moragas A; Pauer J; Pfeiferová M; Radzeviciene-Jurgute R; Sundvall PD; Torres A; Touboul P; Varthalis D; Verheij T; Butler CC
    BMJ Open; 2018 Jul; 8(7):e021032. PubMed ID: 30002007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy, safety and impact on antimicrobial resistance of duration and dose of amoxicillin treatment for young children with Community-Acquired Pneumonia: a protocol for a randomIsed controlled Trial (CAP-IT).
    Lyttle MD; Bielicki JA; Barratt S; Dunn D; Finn A; Harper L; Jackson P; Powell CVE; Roland D; Stohr W; Sturgeon K; Wan M; Little P; Faust SN; Robotham J; Hay AD; Gibb DM; Sharland M;
    BMJ Open; 2019 May; 9(5):e029875. PubMed ID: 31123008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HOspitalised Pneumonia Extended (HOPE) Study to reduce the long-term effects of childhood pneumonia: protocol for a multicentre, double-blind, parallel, superiority randomised controlled trial.
    Chang AB; Fong SM; Yeo TW; Ware RS; McCallum GB; Nathan AM; Ooi MH; de Bruyne J; Byrnes CA; Lee B; Nachiappan N; Saari N; Torzillo P; Smith-Vaughan H; Morris PS; Upham JW; Grimwood K
    BMJ Open; 2019 Apr; 9(4):e026411. PubMed ID: 31023759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotics for lower respiratory tract infection in children presenting in primary care in England (ARTIC PC): a double-blind, randomised, placebo-controlled trial.
    Little P; Francis NA; Stuart B; O'Reilly G; Thompson N; Becque T; Hay AD; Wang K; Sharland M; Harnden A; Yao G; Raftery J; Zhu S; Little J; Hookham C; Rowley K; Euden J; Harman K; Coenen S; Read RC; Woods C; Butler CC; Faust SN; Leydon G; Wan M; Hood K; Whitehurst J; Richards-Hall S; Smith P; Thomas M; Moore M; Verheij T
    Lancet; 2021 Oct; 398(10309):1417-1426. PubMed ID: 34562391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of Chou-Ling-Dan granules in the treatment of seasonal influenza via combining Western and traditional Chinese medicine: protocol for a multicentre, randomised controlled clinical trial.
    He J; Li Z; Huang W; Guan W; Ma H; Yang ZF; Wang X
    BMJ Open; 2019 Apr; 9(4):e024800. PubMed ID: 30944133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Life Interventions for Childhood Growth and Development in Tanzania (ELICIT): a protocol for a randomised factorial, double-blind, placebo-controlled trial of azithromycin, nitazoxanide and nicotinamide.
    DeBoer MD; Platts-Mills JA; Scharf RJ; McDermid JM; Wanjuhi AW; Gratz J; Svensen E; Swann JR; Donowitz JR; Jatosh S; Houpt ER; Mduma E
    BMJ Open; 2018 Jul; 8(7):e021817. PubMed ID: 29982218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial.
    Fry AM; Goswami D; Nahar K; Sharmin AT; Rahman M; Gubareva L; Azim T; Bresee J; Luby SP; Brooks WA
    Lancet Infect Dis; 2014 Feb; 14(2):109-18. PubMed ID: 24268590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ergoferon liquid dosage form--efficacious and safe treatment for childhood acute respiratory infections. Interim outcomes of a multi-center, randomized, double-blind, placebo-controlled clinical trial].
    Geppe NA; Kondiurina EG; Galustian AN; Pak TE; Bal'tserovich NB; Zhiglinskaia OV; Kamaev AV; Lazareva SG; Laléko SL; Mel'nikova IM; Perminova OA; Sabitov AU
    Antibiot Khimioter; 2014; 59(5-6):6-14. PubMed ID: 25552038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RAIN study: a protocol for a randomised controlled trial evaluating efficacy, safety and cost-effectiveness of intravenous-to-oral antibiotic switch therapy in neonates with a probable bacterial infection.
    Keij FM; Kornelisse RF; Hartwig NG; Mauff K; Poley MJ; Allegaert K; Reiss IKM; Tramper-Stranders GA
    BMJ Open; 2019 Jul; 9(7):e026688. PubMed ID: 31289068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
    Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
    Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchiectasis exacerbation study on azithromycin and amoxycillin-clavulanate for respiratory exacerbations in children (BEST-2): study protocol for a randomized controlled trial.
    Chang AB; Grimwood K; Wilson AC; van Asperen PP; Byrnes CA; O'Grady KA; Sloots TP; Robertson CF; Torzillo PJ; McCallum GB; Masters IB; Buntain HM; Mackay IM; Ungerer J; Tuppin J; Morris PS
    Trials; 2013 Feb; 14():53. PubMed ID: 23421781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azithromycin for episodes with asthma-like symptoms in young children aged 1-3 years: a randomised, double-blind, placebo-controlled trial.
    Stokholm J; Chawes BL; Vissing NH; Bjarnadóttir E; Pedersen TM; Vinding RK; Schoos AM; Wolsk HM; Thorsteinsdóttir S; Hallas HW; Arianto L; Schjørring S; Krogfelt KA; Fischer TK; Pipper CB; Bønnelykke K; Bisgaard H
    Lancet Respir Med; 2016 Jan; 4(1):19-26. PubMed ID: 26704020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.